Applied Genetic Technologies

$3.83
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

-$0.02 (-0.52%) As of 3:21 PM EDT today
-$0.02 (-0.52%) Today

Why Robinhood?

You can buy or sell AGTC and other stocks, options, ETFs, and crypto commission-free!

About AGTC

Applied Genetic Technologies Corp. engages in the development of gene therapy platform to develop transformational genetic therapies for patients suffering from rare and debilitating diseases. It has clinical trials in the field of ophthalmology, optogenetics, adrenoleukodystrophy, and otology. Read More The company was founded by Richard Jude Samulski, Nicholas Muzyczka, William W. Hauswirth, Terence R. Flotte, and Barry J. Byrne on January 19, 1999 and is headquartered in Alachua, FL.

Employees
78
Headquarters
Alachua, Florida
Founded
1999
Market Cap
69.96M
Price-Earnings Ratio
39.41
Dividend Yield
0.00
Average Volume
129.19K
High Today
$3.92
Low Today
$3.68
Open Price
$3.92
Volume
84.25K
52 Week High
$7.50
52 Week Low
$2.26

Collections

AGTC Earnings

-$0.68
-$0.43
-$0.18
$0.07
Q2 2018
Q3 2018
Q4 2018
Q1 2019
Q2 2019
Q3 2019
Q4 2019
Estimated
Actual
Expected Sep 20, Pre-Market
All investments involve risk and the past performance of a security, or financial product does not guarantee future results or returns. Securities offered through Robinhood Financial LLC, member FINRA/SIPC. To learn more about the information provided on this page, please see our Web Disclosures.